Abstract
This study was to investigate whether the common polymorphisms of CD40 and CTLA4 genes confer susceptibility to AITD in the Chinese population. A set of unrelated subjects including 303 GD patients, 208 HT patients, and 215 matched healthy controls were recruited. SNPs were genotyped by the method of PCR-RFLP. (1) As for CD40 C/T-1 SNP, only a significant difference was found in allele frequencies between GD and control groups (P = 0.033). (2) On the part of CTLA-4 A/G49 SNP, significant differences were found in genotype and allele frequencies between GD and control groups (P = 7.0 × 10−5 and P = 0.002, respectively), and similar results were found between HT and control groups (P = 0.015 and P = 0.003, respectively). (3) The logistic regression analysis showed there was no interaction between CD40 and CTLA4 genotypes (P = 0.262). These results indicate that both CTLA-4 A/G49 and CD40 C/T-1 SNPs are associated with genetic susceptibility of GD, and CTLA-4 A/G49 is also associated with HT.
Similar content being viewed by others
References
E.M. Jacobson, Y. Tomer, The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J. Autoimmun. 28, 85–98 (2007)
A. Kurylowicz, D. Kula, R. Ploski, A. Skorka, B. Jurecka-Lubieniecka, J. Zebracka, K. Steinhof-Radwanska, K. Hasse-Lazar, Y. Hiromatsu, B. Jarzab, T. Bednarczuk, Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves’ disease. Thyroid 15, 1119–1124 (2005)
T. Mukai, Y. Hiromatsu, T. Fukutani, M. Ichimura, H. Kaku, I. Miyake, K. Yamada, A C/T polymorphism in the 5′ untranslated region of the CD40 gene is associated with later onset of Graves’ disease in Japanese. Endocr. J. 52, 471–477 (2005)
J.Y. Hsiao, K.J. Tien, C.T. Hsiao, M.C. Hsieh, A C/T polymorphism in CD40 gene is not associated with susceptibility and phenotype of Graves’ disease in Taiwanese. Endocr. J. 55, 477–484 (2008)
T. Yanagawa, M. Taniyama, S. Enomoto, K. Gomi, H. Maruyama, Y. Ban, T. Saruta, CTLA4 gene polymorphism confers susceptibility to Graves’ disease in Japanese. Thyroid 7, 843–846 (1997)
T. Yanagawa, Y. Hidaka, V. Guimaraes, M. Soliman, L.J. DeGroot, CTLA-4 gene polymorphism associated with Graves’ disease in a Caucasian population. J. Clin. Endocrinol. Metab. 80, 41–45 (1995)
Y.J. Park, H.K. Chung, D.J. Park, W.B. Kim, S.W. Kim, J.J. Koh, B.Y. Cho, Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10, 453–459 (2000)
E. Yung, P.S. Cheng, T.F. Fok, G.W. Wong, CTLA-4 gene A–G polymorphism and childhood Graves’ disease. Clin. Endocrinol. (Oxf) 56, 649–653 (2002)
S.X. Zhao, C.M. Pan, H.M. Cao, B. Han, J.Y. Shi, J. Liang, G.Q. Gao, Y.D. Peng, Q. Su, J.L. Chen, J.J. Zhao, H.D. Song, Association of the CTLA4 gene with Graves’ disease in the Chinese Han Population. PLoS One 5, e9821 (2010)
M. Maierhaba, J.A. Zhang, Z.Y. Yu, Y. Wang, W.X. Xiao, Y. Quan, B.N. Dong, Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese population. Endocrine 33, 294–299 (2008)
A.K. Huber, E.M. Jacobson, K. Jazdzewski, E.S. Concepcion, Y. Tomer, Interleukin (IL)-23 receptor is a major susceptibility gene for Graves’ ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 93, 1077–1081 (2008)
Y. Tomer, E. Concepcion, D.A. Greenberg, A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves’ disease. Thyroid 12, 1129–1135 (2002)
E.A. Clark, J.A. Ledbetter, Activation of human B-cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83, 4494–4498 (1986)
E.M. Jacobson, E. Concepcion, T. Oashi, Y. Tomer, A Graves’ disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146, 2684–2691 (2005)
S.D. Katzman, E. Gallo, K.K. Hoyer, A.K. Abbas, Differential requirements for Th1 and Th17 responses to a systemic self-antigen. J. Immunol. 186, 4668–4673 (2011)
T.J. Smith, D. Sciaky, R.P. Phipps, T.A. Jennings, CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases. Thyroid 9, 749–755 (1999)
T.Y. Kim, Y.J. Park, J.K. Hwang, J.Y. Song, K.S. Park, B.Y. Cho, D.J. Park, A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves’ disease in Koreans. Thyroid 13, 919–925 (2003)
Y. Ban, T. Tozaki, M. Taniyama, M. Tomita, Y. Ban, Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with Graves’ disease in Japanese. Thyroid 16, 443–446 (2006)
J.F. Brunet, F. Denizot, M.F. Luciani, M. Roux-Dosseto, M. Suzan, M.G. Mattei, P. Golstein, A new member of the immunoglobulin superfamily-CTLA-4. Nature 328, 267–270 (1987)
P. Waterhouse, J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, T.W. Mak, Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985–988 (1995)
T. Kouki, Y. Sawai, C.A. Gardine, M.E. Fisfalen, M.L. Alegre, L.J. DeGroot, CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J. Immunol. 165, 6606–6611 (2000)
T. Kouki, C.A. Gardine, T. Yanagawa, L.J. Degroot, Relation of three polymorphisms of the CTLA-4 gene in patients with Graves’ disease. J. Endocrinol. Invest. 25, 208–213 (2002)
R. Nithiyananthan, J.M. Heward, A. Allahabadia, J.A. Franklyn, S.C. Gough, Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 12, 3–6 (2002)
J.M. Heward, A. Allahabadia, M. Armitage, A. Hattersley, P.M. Dodson, K. Macleod, J.C. Smith, J. Daykin, A. Daly, M.C. Sheppard, R.L. Holder, A.H. Barnett, J.A. Franklyn, S.C.L. Gough, The development of Graves’ disease and the CTLA-4 gene on chromosome 2q33. J. Clin. Endocrinol. Metab. 84, 2398–2401 (1999)
Y. Kinjo, N. Takasu, I. Komiya, T. Tomoyose, M. Takara, T. Kouki, Y. Shimajiri, K. Yabiku, H. Yoshimura, Remission of Graves’ hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene. J. Clin. Endocrinol. Metab. 87, 2593–2596 (2002)
F.K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D.A. Chistiakov, I. Frydecka, A. Ghaderi, S.C. Gough, Y. Hiromatsu, R. Ploski, P.W. Wang, Y. Ban, T. Bednarczuk, E.I. Chistiakova, M. Chojm, J.M. Heward, H. Hiratani, S.H. Juo, L. Karabon, S. Katayama, S. Kurihara, R.T. Liu, I. Miyake, G.H. Omrani, E. Pawlak, M. Taniyama, T. Tozaki, J.P. Ioannidis, CTLA-4 gene polymorphisms and autoimmune thyroid disease: a meta analysis. J. Clin. Endocrinol. Metab. 92, 3162–3170 (2007)
M. Sahin, M.F. Erdogan, G. Erdogan, Cytotoxic T lymphocyte-associated molecule-4 polymorphisms in Turkish Graves’ disease patients and association with probability of remission after antithyroid therapy. Eur. J. Intern. Med. 16, 352–355 (2005)
M. Sahin, A. Gursoy, M.F. Erdogan, Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis. Int. J. Immunogenet. 36, 103–106 (2009)
Acknowledgments
This project was supported by the National Natural Science Foundation of China (No. 30871185).
Author information
Authors and Affiliations
Corresponding author
Additional information
Jing Yang and Qiu Qin contributed equally in this study.
Rights and permissions
About this article
Cite this article
Yang, J., Qin, Q., Yan, N. et al. CD40 C/T-1 and CTLA-4 A/G49 SNPs are associated with autoimmune thyroid diseases in the Chinese population. Endocrine 41, 111–115 (2012). https://doi.org/10.1007/s12020-011-9510-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9510-1